Complex dichotomous links of nonalcoholic fatty liver disease and inflammatory bowel disease: exploring risks, mechanisms, and management modalities
Open Access
- 30 October 2024
- journal article
- review article
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (4) , 414-427
Abstract
Nonalcoholic fatty liver disease (NAFLD) has been shown to be linked to inflammatory bowel disease (IBD) due to established risk factors such as obesity, age, and type 2 diabetes in numerous studies. However, alternative research suggests that factors related to IBD, such as disease activity, duration, and drug-induced toxicity, can contribute to NAFLD. Recent research findings suggest IBD relapses are correlated with dysbiosis, mucosal damage, and an increase in cytokines. In contrast, remission periods are characterized by reduced metabolic risk factors. There is a dichotomy evident in the associations between NAFLD and IBD during relapses and remissions. This warrants a nuanced understanding of the diverse influences on disease manifestation and progression. It is possible to provide a holistic approach to care for patients with IBD by emphasizing the interdependence between metabolic and inflammatory disorders.Keywords
This publication has 88 references indexed in Scilit:
- Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterationsCell Metabolism, 2023
- Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese AdultsClinical Gastroenterology and Hepatology, 2022
- Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk FactorsClinical Gastroenterology and Hepatology, 2022
- Non-invasive diagnosis and follow-up of non-alcoholic fatty liver diseaseClinics and Research in Hepatology and Gastroenterology, 2022
- Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7‐Year Longitudinal StudyHepatology, 2018
- Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease PatientsDigestive Diseases and Sciences, 2017
- Novel insights on interactions between folate and lipid metabolismBioFactors, 2013
- Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel diseaseJournal of Crohn's and Colitis, 2013
- Bile Acid Metabolism and Signaling2013
- The retinoid X receptors and their ligandsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012